You searched for: trapjantat (Maltesiska - Engelska)

reċipjenti fi fwied trapjantat
liver transplant recipients

riġezzjoni ta ’ l- organu trapjantat.
rejection of your transplanted organ.

imma dan jiddependi mill- organu trapjantat.
depending on the transplanted organ.

nuqqas ta’ ħidma fl-organu trapjantat.
insufficient function of your transplanted organ

cellcept jintuża biex ma jħallix lill-ġisem tiegħek jiċħad organu trapjantat.
cellcept is used to prevent your body rejecting a transplanted organ.

myfenax jintuża biex jimpedixxi ’l ġisemek milli jirriġetta kliewi, qalb jew fwied trapjantat.
myfenax is used to prevent your body rejecting a transplanted kidney, heart or liver.

mycophenolate mofetil teva jintuża biex jimpedixxi ’l ġisemek milli jirriġetta kliewi, qalb jew fwied trapjantat.
mycophenolate mofetil teva is used to prevent your body rejecting a transplanted kidney, heart or liver.

il-kura se tkompli sakemm ikollok bżonn biex tipprevjeni li tiċħad l-organu trapjantat tiegħek.
treatment will continue for as long as you need to prevent you from rejecting your transplant organ.

is- sistema immuni tal-ġisem taħseb li organu trapjantat huwa oġġett barrani, u tipprova tirriġettah.
the body’s immune system thinks a transplanted organ is a foreign body and will try to reject it.

iż-żmien totali ta’ trattament rakkomandat għal pazjenti li kellhom fwied trapjantat hu ta’ 48 ġimgħa.
the recommended total duration of treatment for patients who have received a liver transplant is 48 weeks.

advagraf jintuża biex jikkontrolla r-respons immuni ta’ ġismek billi jgħin lil ġismek jaċcetta l-organu trapjantat.
advagraf is used to control your body’s immune response, enabling your body to accept the transplanted organ.

dawn il-mediċini jgħinu sabiex iwaqqfu r-risposta naturali tal-ġisem milli jirrifjuta l-organu trapjantat.
these medicines help to suppress your body’s natural response to reject your transplanted organ.

jekk twaqqaf it-trattament tiegħek b’myfenax jista’ jiżdied iċ-ċans għal riġezzjoni tal-organu trapjantat.
stopping your treatment with myfenax may increase the chance of rejection of your transplanted organ.

envarsus jintuża biex jikkontrolla r-rispons immuni ta’ ġismek, u b’hekk jippermetti li ġismek jaċċetta l-organu trapjantat.
envarsus is used to control your body’s immune response, enabling your body to accept the transplanted organ.

id-doża li ssoltu tibda biha biex tevita rifjut tal-organu trapjantat jiddeċidiha t-tabib skont il-piż ta’ ġismek.
the starting dose to prevent the rejection of your transplanted organ will be determined by your doctor calculated according to your body weight.

ciclosporin (jintuża biex jiġi evitat li l-ġisem jirriġetta organu trapjantat jew għal kondizzjonijiet oħra, bħall-artrite rewmatika jew dermatite atopika),
ciclosporin (used to prevent the body rejecting a transplanted organ or for other conditions, such as rheumatoid arthritis or atopic dermatitis),

jekk twaqqaf it-trattament tiegħek b’mycophenolate mofetil teva jista’ jiżdied iċ-ċans għal riġezzjoni ta’ l-organu trapjantat.
stopping your treatment with mycophenolate mofetil teva may increase the chance of rejection of your transplanted organ.